Skip to main content
TipRanks
Go Ultimate75% OFF

Oruka Therapeutics (ORKA) Stock Forecast & Price Target

859 Followers
See the Price Targets and Ratings of:

ORKA Analyst Ratings

Strong Buy
12Ratings
12Buy0Hold0Sell
Based on 12 analysts giving stock ratings to Oruka Therapeutics in the past 3 months

ORKA Stock 12 Month Forecast

$153.60▲(45.80% Upside)
Based on 12 Wall Street analysts offering 12 month price targets for Oruka Therapeutics in the last 3 months. The average price target is $153.60 with a high forecast of $200.00 and a low forecast of $105.00. The average price target represents a 45.80% change from the last price of $105.35.
Highest Price Target$200.00Average Price Target$153.60Lowest Price Target$105.00

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for ORKA
Price TargetArticle
Barclays$160buy51.87%UpsideReiterated11/10/26
H.C. Wainwright$120buy13.91%UpsideReiterated11/10/26
Stifel Nicolaus$150buy42.38%UpsideReiterated11/10/26
Piper Sandler$180buy70.86%UpsideReiterated11/10/26
UBS$130buy23.40%UpsideReiterated11/10/26
BTIG$151buy43.33%UpsideReiterated11/09/26
Guggenheim Analyst forecast on ORKAUnknown AnalystNot RankedGuggenheim$200buy89.84%UpsideReiterated11/09/26
Wedbush$165buy56.62%UpsideReiterated10/27/26
Leerink Partners―buy―Reiterated10/27/26
Clear Street$131→$105buy-0.33%DownsideReiterated10/26/26
LifeSci Capital$175buy66.11%UpsideReiterated09/23/26
TD Cowen―buy―Reiterated08/26/26
Jefferies$133buy26.25%UpsideReiterated08/11/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
MDWDMediwound
OVIDOvid Therapeutics
IMUXImmunic
QUITAchieve Life Sciences
COGTCogent Biosciences

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Oruka Therapeutics

3 Months
Success Rate10/12 ratings generated profit
83%
Average Return
+53.48%

Copying Julian Harrison's trades and holding each position for 3 Months would result in 83.33% of your transactions generating a profit, with an average return of +53.48% per trade.

1 Year
Mitchell Kapoor
Mitchell KapoorH.C. Wainwright
Success Rate15/16 ratings generated profit
94%
Average Return
+197.49%

Copying Mitchell Kapoor's trades and holding each position for 1 Year would result in 93.75% of your transactions generating a profit, with an average return of +197.49% per trade.

2 Years
David Risinger
David RisingerLeerink Partners
Success Rate13/13 ratings generated profit
100%
Average Return
+419.88%

Copying David Risinger's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +419.88% per trade.

ORKA Analyst Recommendation Trends

010203040Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26
Monthly rating counts for ORKA
RatingJul 26Aug 26Sep 26Oct 26Nov 26
Strong Buy1413131713
Buy4791111
Hold00000
Sell00000
Strong Sell00000
total1820222824

In the current month, ORKA has received 24 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. ORKA average Analyst price target in the past 3 months is 153.60.

ORKA Financial Forecast

$-2$-1.5$-1$-0.5$0Q1 2026Q3 2026Q4 2026
High$-0.60
Consensus$-0.75
Low$-1.00

ORKA Earnings Forecast

Next quarter’s earnings estimate for ORKA is -$0.75 with a range of -$1.00 to -$0.60. The previous quarter’s EPS was -$0.63. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

$-1$-0.5$0$0.5$1Q1 2026Q3 2026Q4 2026
High$0.00
Consensus$0.00
Low$0.00

ORKA Sales Forecast

Next quarter’s sales forecast for ORKA is $0 with a range of $0 to $0. The previous quarter’s sales results were $0. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

ORKA Stock Forecast FAQ

What is ORKA’s average 12-month price target, according to analysts?
Based on analyst ratings, Oruka Therapeutics’s 12-month average price target is $153.60.
What is ORKA’s upside potential, based on the analysts’ average price target?
Oruka Therapeutics has 45.80% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is ORKA a Buy, Sell or Hold?
Oruka Therapeutics has a consensus rating of Strong Buy which is based on 12 buy ratings, 0 hold ratings and 0 sell ratings.
What is Oruka Therapeutics’s price target?
The average price target for Oruka Therapeutics is $153.60. This is based on 12 12-month price targets, issued in the past 3 months. The highest analyst price target is $200.00, the lowest forecast is $105.00. The average price target represents a 45.80% increase from the current price of $105.35.
What do analysts say about Oruka Therapeutics?
Oruka Therapeutics’s analyst rating consensus is a Strong Buy. This is based on the ratings of 12 Wall Street analysts.
How can I buy shares of ORKA?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.